H.R. 2891 · 117th Congress

Preserve Access to Affordable Generics and Biosimilars Act

Stage
Reported from committee
Sponsor
Jerrold Nadler
Introduced
2021-04-28
Latest action
2021-09-29 · Committee Consideration and Mark-up Session Held.

Action history

  1. 2021-09-29Committee Consideration and Mark-up Session Held.
  2. 2021-09-29Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.
  3. 2021-04-29Referred to the Subcommittee on Health.
  4. 2021-04-28Introduced in House
  5. 2021-04-28Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  6. 2021-04-28Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.